MDCX Stock Overview

A biotech/life sciences company, focuses on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. More details

MDCX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the US market

Does not have a meaningful market cap ($46M)

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

Medicus Pharma Ltd. Competitors

RenovoRx

NasdaqCM:RNXT

US$33.1m

AgeX Therapeutics

NYSEAM:AGE

US$31.5m

ProMIS Neurosciences

NasdaqCM:PMN

US$34.0m

Neoleukin Therapeutics

NasdaqCM:NLTX

US$32.8m

Price History & Performance

Summary of share price highs, lows and changes for Medicus Pharma
Historical stock prices
Current Share Price	CA$2.51
52 Week High	CA$6.00
52 Week Low	CA$1.80
Beta	0
1 Month Change	-16.05%
3 Month Change	-28.69%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-38.78%

Recent updates

Shareholder Returns

	MDCX	US Biotechs	US Market
7D	-3.5%	0.2%	-0.2%
1Y	n/a	-4.7%	25.8%

Return vs Industry: Insufficient data to determine how MDCX performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how MDCX performed against the US Market.

Price Volatility

Is MDCX's price volatile compared to industry and market?
MDCX volatility
MDCX Average Weekly Movement	25.5%
Biotechs Industry Average Movement	11.0%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: MDCX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MDCX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Raza Bokhari	medicuspharma.com

Medicus Pharma Ltd., a biotech/life sciences company, focuses on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. It is developing SkinJect with an indication for basal cell carcinoma. The company is headquartered in Toronto, Canada.

Medicus Pharma Ltd. Fundamentals Summary

How do Medicus Pharma's earnings and revenue compare to its market cap?
MDCX fundamental statistics
Market cap	US$32.06m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is MDCX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDCX income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MDCX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/05 10:57
End of Day Share Price	2025/01/03 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medicus Pharma Ltd. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kumaraguru Raja	Brookline Capital Markets
Jason McCarthy	Maxim Group
Steven Ralston	Zacks Small-Cap Research